Edward Stelmakh - 11 Oct 2021 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
COO and CFO
Signature
/s/ Edward Stelmakh
Issuer symbol
OPRX
Transactions as of
11 Oct 2021
Net transactions value
$0
Form type
4
Filing time
13 Oct 2021, 16:45:33 UTC
Previous filing
21 Feb 2024
Next filing
17 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Award $0 +24,664 $0.000000 24,664 11 Oct 2021 Common Stock 24,664 Direct F1, F2, F3
transaction OPRX Stock Option Award $0 +25,191 $0.000000 25,191 11 Oct 2021 Common Stock 25,191 $81.09 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted will vest 1/3 at the end of each anniversary from issuance, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction.
F3 Not applicable.
F4 The Stock Option will vest 1/3 at the end of each anniversary from issuance.